covid-19 testing DNA

Covid-19: Entos and Takis to work on separate vaccines

Reading now: 180
www.pharmaceutical-technology.com

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Entos Pharmaceuticals is set to develop a DNA vaccine for Covid-19 coronavirus infection using its Fusogenix drug delivery platform.

A DNA vaccine directly delivers a plasmid encoding the antigen(s) to generate an immune response. It involves the generation of the target antigen in the patient’s own cells.

The Fusogenix platform is a proteo-lipid vehicle (PLV) designed to leverage a fusion mechanism to introduce its genetic payload directly inside cells.

Entos created different formulations to deliver various genetic therapies, including plasmid DNA. Plasmid DNA in a vaccine is expected to enable the design of an optimised payload that encodes several

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA